Literature DB >> 482609

Isobologram analysis of X-ray--BCNU interactions in vitro.

D F Deen, M E Williams.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 482609

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  13 in total

1.  Theoretical models for estimating dose-effect relationships after combined exposure to cytotoxicants.

Authors:  B R Scott
Journal:  Bull Math Biol       Date:  1983       Impact factor: 1.758

2.  Interactions: dose effect relationships and isoeffect curves.

Authors:  G B Gerber
Journal:  Radiat Environ Biophys       Date:  1982       Impact factor: 1.925

3.  Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.

Authors:  J P Eder; B A Teicher; S A Holden; K N Cathcart; L E Schnipper
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

4.  Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline.

Authors:  J P Eder; B A Teicher; S A Holden; L Senator; K N Cathcart; L E Schnipper
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro.

Authors:  K W Rosbe; T W Brann; S A Holden; B A Teicher; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Influence of scheduling on two-drug combinations of alkylating agents in vivo.

Authors:  B A Teicher; S A Holden; S M Jones; J P Eder; T S Herman
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  The 9L rat brain tumor: description and application of an animal model.

Authors:  M Weizsaecker; D F Deen; M L Rosenblum; T Hoshino; P H Gutin; M Barker
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

8.  In vitro studies on drug interaction of ifosfamide and ACNU in primary and metastatic human brain tumours.

Authors:  U Bogdahn; D Drenkard; M Lutz; R Apfel; C Behl
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

9.  Cyclocreatine in cancer chemotherapy.

Authors:  B A Teicher; K Menon; D Northey; J Liu; D W Kufe; R Kaddurah-Daouk
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

10.  Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.

Authors:  S A Holden; B A Teicher; M F Robinson; D Northey; A Rosowsky
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.